| 1. |
Kawashiri T, Kobayashi D, Uchida M, Hiromoto S, Inoue M, Ikeda H, Inoue M, Shimazoe T, Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS), ACCP 2022 (21st Asian Conference on Clinical Pharmacy), 2022.02. |
| 2. |
Niimura T, Zamami Y, Naitoh Y, Kawashiri T, Goda M, Yagi K, Chuma M, Izawa-Ishizawa Y, Ishizawa K, Search for preventive drugs for drug-induced neuropathy using medical information database, CBI学会2020年大会, 2020.10. |
| 3. |
Shimazoe T, Kubota T, Kobayashi D, Kawashiri T, Kihara T, Takaki J, Koyanagi K, Nakashiba T, Kawanami M, Tsuzuki K, Nagatomi S, Tanaka T, Assessment of non-adherence factors using original score sheets in SETSUYAKU-BAG Campaign of Japan, FIP 2018, 2018.09. |
| 4. |
Kawashiri T, Miyagi A, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe S., Dimethyl fumarate ameliorates chemotherapy agent-induced peripheral neuropathy, WCP2018 the 18th World Congress of Basic and Clinical Pharmacology , 2018.07. |
| 5. |
Suetsugu K, Ikesue H, Uchida M, Yano T, Watanabe H, Yamada T, Kawashiri T, Kajiwara M, Miyamoto T, Shiratsuchi M, Egashira N, Masuda S, Analysis of the variable factors in the blood tacrolimus concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation, IATDMCT2015, 2015.10. |
| 6. |
Kawashiri T, Tsutsumi K, Ushio S, Egashira N, Masuda S, Prophylactic effect of calcium channel blockers against oxaliplatin-induced acute peripheral neuropathy., Experimental Biology 2014, 2014.04. |
| 7. |
Ushio S, Mitsuyasu S, Masuguchi K, Ozawa N, Ono Y, Kawashiri T, Egashira N, Masuda S, Association between decreased expression of GLT-1 derived spinal glutamate accumulation and oxaliplatin-induced mechanical allodynia , Experimental Biology 2014, 2014.04. |
| 8. |
Oishi R, Tatsushima Y, Narishige Y, Kawashiri T, Egashira N, Calcium channel antagonists prevent oxaliplatin-induced acute peripheral neuropathy; Retrospective analysis, 2011 ASHP Midyear Clinical Meeting, 2011.12. |
| 9. |
Egashira N, Kawashiri T, Watanabe H, Ikegami Y, Yano T, Ikesue H, Oishi R, Neurotropin relieves the oxaliplatin-induced peripheral neuropathy by inhibiting neurodegeneration, WorldPharma 2010、16th World Congress on Basic and Clinical Pharmacology, 2010.07. |
